http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2624859-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72b28a627c615c5fb1ab1d13943e47d5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d1f445bc5c0f9344f3445012804a5a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c56f92d20e8ce43002a13937bd3338fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bcb5fac5297465fef3534841978b838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbcda08072b1e60395ecd6c29f3f34d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f585084eb5a71813b9b757afc7b24f70 |
| publicationDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2624859-C1 |
| titleOfInvention | Method for estimation of increased risk of phlebothromboses formation in patients with ischemic heart disease |
| abstract | FIELD: medicine. n SUBSTANCE: method involves determination of rheological characteristics of venous blood after venous occlusion, at that the unaligned venous blood parameters are determined twice before and after a single venous occlusion with low frequency piezoeleastography: t1 is the reaction period representing the time from the beginning of study to the maximum amplitude decrease, A 1 , minutes; t2 is the time to reach A 2 amplitude , minutes; t3 is an indicator that displays blood coagulation time, minutes, determined automatically, when the tg angle of the curve changes by 60%; MA is the maximum amplitude, an indicator characterizing the end of formation of a cross-linked fibrin clot subjected to retraction, A1-max is amplitude decrease during "t1" time - the reaction period, p.u. A6 is the amplitude value 10 minutes after reaching the maximum amplitude, p.u. Further, the constant of thrombin activity CTA is calculated by the formula: CTA=100/(t2-t1), as well as the intensity of retraction and lysis of the IRLS clot by the formula: IRLS=[MA-(A6-A1)/100]*100%. At CTA increase of 20% or more, t3 decrease by 30% or more and no change or decrease in IRLS, an increased risk of phlebothrombosis is diagnosed. n EFFECT: use of the invention allows to increase accuracy and informative value while reducing the traumatic nature of the study. n 5 dwg, 3 tbl, 4 ex |
| priorityDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.